IP Library Granted Patent US 7,019,019
Granted Patent B2
US 7,019,019 · App. 10/740,946 · Granted Mar 28, 2006

Matriptase inhibitors and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,019,019
App. No.
10/740,946
Granted
Mar 28, 2006
Kind
B2
Abstract

The present invention provides matriptase inhibitors and compositions thereof useful for treating cancer. Martripase is a trypsin-like serine protease active in the development of cancerous conditions, such as tumors and metastasis of cancer.

Claims (207)

1. A compound of the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkyl, an optionally substituted C 1 -C 8 alkoxy, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted carboxy, an optionally substituted carboxyalkyl, an optionally substituted carboxyalkenyl, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted carbamoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylalkyl, an optionally substituted C 1 -C 8 alkylthio, an optionally substituted C 1 -C 8 alkylsulfinyl, an optionally substituted C 1 -C 8 alkylsulfonyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aryl, an optionally substituted arylsulfinyl, an optionally substituted arylsulfonyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonyl, an optionally substituted amino, and an acid isostere;

n is a value of 0 to about 6;

R 2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylalkyl, an optionally substituted amino, an optionally substituted carbamoyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroararyl, an optionally substituted cycloalkyl, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy; or

R 1 , R 2 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;

R 3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group; or

R 1 and R 3 , or R 2 and R 3 , together with the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;

R 4 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl; or

R 3 , R 4 , or R 2 , R 4 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;

R 5 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl, an optionally substituted aralkyl, or, alternatively, R 4 , R 5 and the atoms to which they are attached, join to form a 5- or 6-membered heterocyclic or heteroaryl ring;

R 6 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl; or

R 5 , R 6 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;

‘A’ is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkylene, a five- or a six-membered optionally substituted cycloalkyl group, a 5 to 10-membered optionally substituted aryl group and a 5 to 10-membered optionally substituted heteroaryl group, wherein said 5 to 10-membered optionally substituted heteroaryl group has from 1 to 3 heteroatoms selected from the group consisting of optionally substituted N, O, and S, wherein ‘A’ can optionally have a heteroatom for attachment;

X is a heteroatom selected from the group consisting of S, O and N;

R 7 , if present, is a member selected from the group consisting of hydrogen, hydroxy, an optionally substituted C 1 -C 8 alkyl, an optionally substituted C 1 -C 8 alkoxy, an optionally substituted aryl, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted C 1 -C 8 alkanoyloxy, an optionally substituted alkylcarbamoyl, an optionally substituted alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonyloxy; alternatively, A, R 7 , and the atoms to which they are attached, join to form a 5- to 10-membered optionally substituted heteroaryl group, wherein said 5- to 10-membered optionally substituted heteroaryl group has at least 1 optionally substituted nitrogen and the dotted line is either a bond or is absent; and

R 8 and R 9 are members independently selected from the group consisting of hydrogen, hydroxy, an optionally substituted C 1 -C 8 alkyl, an optionally substituted alkoxy, an optionally substituted aryl, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted alkanoyloxy, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted alkoxycarbonyl, and an optionally substituted C 1 -C 8 alkoxycarbonyloxy, in an alternative embodiment, R 7 and R 9 and the atoms to which they are attached, join to form a 5- to 7-membered heterocyclic or heteroaryl ring.

2. The compound of claim 1 , wherein

is a member selected from the group consisting of:

wherein R 11 is a member selected from the group consisting of hydrogen, hydroxyl, and an optionally substituted C 1 -C 8 alkyl; and

Q, Y and Z are each independently selected from the group consisting of an optionally substituted carbon, an optionally substituted nitrogen, an oxygen and a sulfur, provided however at least one of Q, Y and Z is carbon and wherein the dotted line is an optional double bond.

3. The compound of claim 2 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkoxy, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted amino, an optionally substituted carbamoyl, an optionally substituted C 1 -C 8 alkylsulfonyl, an optionally substituted aryl, optionally substituted arylsulfonyl, and a carboxylic acid isostere;

n is a value of about 1 to 4;

R 2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted amino, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy;

R 3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted aralkyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted heteroaralkyl, and an optionally substituted carboxy; and

R 5 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl.

4. The compound of claim 3 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkoxy, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted amino, and an optionally substituted carboxy an optionally substituted carbamoyl, an optionally substituted C 1 -C 8 alkylsulfonyl, an optionally substituted aralkylsulfonyl, optionally substituted arylsulfonyl, and an acid isostere;

n is a value of about 1 to 2;

R 2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted amino, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted carbamoyl, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, an optionally substituted arylsulfonylcarbamoyl and hydroxy; and

R 6 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl.

5. The compound of claim 3 , wherein R 2 is selected from an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted ureido, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and hydroxy.

6. The compound of claim 3 , wherein R 2 is an optionally substituted C 1 -C 8 alkoxycarbonyl.

7. The compound of claim 2 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an C 1 -C 6 alkyl, carboxyl group, C 1 -C 6 alkyl-OC(O)NH—, C 1 -C 6 alkylOC(O)—, C 1 -C 6 alkylC(O)—, C 1 -C 6 alkylSO 2 —, C 1 -C 6 alkylOC(O)NR 12 wherein R 12 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl and NR 13 R 14 C(O)—, wherein R 13 R 14 are each independently selected from the group of hydrogen, and an optionally substituted C 1 -C 8 alkyl.

8. The compound of claim 7 , wherein said compound has the formula

wherein:

R 2 is selected from an optionally substituted alkylcarbamoyl group, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and an optionally substituted ureido.

9. The compound of claim 7 , wherein said compound has the formula

wherein:

R 2 is selected from an optionally substituted C 1 -C 6 alkylcarbamoyl group, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and an optionally substituted ureido.

10. The compound of claim 2 , wherein said compound has the formula

wherein:

R 3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group.

11. The compound of claim 2 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkyl, an optionally substituted C 1 -C 8 alkoxy, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted carboxy, an optionally substituted carboxyalkyl, an optionally substituted carboxyalkenyl, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted carbamoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylalkyl, an optionally substituted C 1 -C 8 alkylthio, an optionally substituted C 1 -C 8 alkylsulfinyl, an optionally substituted C 1 -C 8 alkylsulfonyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aryl, an optionally substituted arylsulfinyl, an optionally substituted arylsulfonyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonyl, an optionally substituted amino, and an acid isostere;

R 3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group; or

R 2 and R 3 , together with the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring.

12. The compound of claim 2 , wherein said compound has the formula

wherein:

R 2 is selected from an optionally substituted C 1 -C 6 alkylcarbamoyl group, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and an optionally substituted ureido.

13. The compound of claim 1 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkoxy, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted carbamoyl, an optionally substituted amino, and an optionally substituted carboxy;

n is a value of about 1 to 2;

R 2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted amino, an optionally substituted carboxy, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy;

R 3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkoxycarbonyl, and an optionally substituted carboxy; and

R 6 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl; and

Q, Y and Z are each independently selected from the group consisting of a carbon, an optionally substituted nitrogen, an oxygen and a sulfur, provided however at least one of Q, Y and Z is carbon.

14. The compound of claim 13 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkoxy, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted carbamoyl, an optionally substituted amino, and an optionally substituted carboxy;

n is a value of about 1 to 2; and

R 2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted amino, and an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy.

15. A pharmaceutical composition, said pharmaceutical composition comprising:

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkyl, an optionally substituted C 1 -C 8 alkoxy, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted carboxy, an optionally substituted carboxyalkyl, an optionally substituted carboxyalkenyl, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted carbamoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylalkyl, an optionally substituted C 1 -C 8 alkylthio, an optionally substituted C 1 -C 8 alkylsulfinyl, an optionally substituted C 1 -C 8 alkylsulfonyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aryl, an optionally substituted arylsulfinyl, an optionally substituted arylsulfonyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonyl, an optionally substituted amino, and an acid isostere;

n is a value of 0 to about 6;

R 2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylalkyl, an optionally substituted amino, an optionally substituted carbamoyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroararyl, an optionally substituted cycloalkyl, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy; or

R 1 , R 2 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;

R 3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group; or

R 1 and R 3 , or R 2 and R 3 , together with the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;

R 4 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl; or

R 3 , R 4 , or R 2 , R 4 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;

R 5 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl, an optionally substituted aralkyl, or, alternatively, R 4 , R 5 and the atoms to which they are attached, join to form a 5- or 6-membered heterocyclic or heteroaryl ring;

R 6 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl; or

R 5 , R 6 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;

‘A’ is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkylene, a five- or a six-membered optionally substituted cycloalkyl group, a 5 to 10-membered optionally substituted aryl group and a 5 to 10-membered optionally substituted heteroaryl group, wherein said 5 to 10-membered optionally substituted heteroaryl group has from 1 to 3 heteroatoms selected from the group consisting of optionally substituted N, O, and S, wherein ‘A’ can optionally have a heteroatom for attachment;

X is a heteroatom selected from the group consisting of S, O and N;

R 7 , if present, is a member selected from the group consisting of hydrogen, hydroxy, an optionally substituted C 1 -C 8 alkyl, an optionally substituted C 1 -C 8 alkoxy, an optionally substituted aryl, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted C 1 -C 8 alkanoyloxy, an optionally substituted alkylcarbamoyl, an optionally substituted alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonyloxy; alternatively, A, R 7 , and the atoms to which they are attached, join to form a 5- to 10-membered optionally substituted heteroaryl group, wherein said 5- to 10-membered optionally substituted heteroaryl group has at least 1 optionally substituted nitrogen and the dotted line is either a bond or is absent; and

R 8 and R 9 are members independently selected from the group consisting of hydrogen, hydroxy, an optionally substituted C 1 -C 8 alkyl, an optionally substituted alkoxy, an optionally substituted aryl, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted alkanoyloxy, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted alkoxycarbonyl, and an optionally substituted C 1 -C 8 alkoxycarbonyloxy, in an alternative embodiment, R 7 and R 9 and the atoms to which they are attached, join to form a 5- to 7-membered heterocyclic or heteroaryl ring.

16. The composition of claim 15 , wherein

is a member selected from the group consisting of:

wherein R 11 is a member selected from the group consisting of hydrogen, hydroxyl, and an optionally substituted C 1 -C 8 alkyl; and

Q, Y and Z are each independently selected from the group consisting of an optionally substituted carbon, an optionally substituted nitrogen, an oxygen and a sulfur, provided however at least one of Q, Y and Z is carbon and wherein the dotted line is an optional double bond.

17. The composition of claim 16 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkoxy, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted amino, an optionally substituted carbamoyl, an optionally substituted C 1 -C 8 alkylsulfonyl, an optionally substituted aryl, optionally substituted arylsulfonyl, and a carboxylic acid isostere;

n is a value of about 1 to 4;

R 2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted amino, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy;

R 3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted aralkyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted heteroaralkyl, and an optionally substituted carboxy; and

R 5 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl.

18. The composition of claim 17 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkoxy, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted amino, and an optionally substituted carboxy an optionally substituted carbamoyl, an optionally substituted C 1 -C 8 alkylsulfonyl, an optionally substituted aralkylsulfonyl, optionally substituted arylsulfonyl, and an acid isostere;

n is a value of about 1 to 2;

R 2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted amino, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted carbamoyl, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, an optionally substituted arylsulfonylcarbamoyl and hydroxy; and

R 6 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl.

19. The composition of claim 17 , wherein R 2 is selected from an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted ureido, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and hydroxy.

20. The composition of claim 17 , wherein R 2 is an optionally substituted C 1 -C 8 alkoxycarbonyl.

21. The composition of claim 16 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an C 1 -C 6 alkyl, carboxyl group, C 1 -C 6 alkyl-OC(O)NH—, C 1 -C 6 alkylOC(O)—, C 1 -C 6 alkylC(O)—, C 1 -C 6 alkylSO 2 —, C 1 -C 6 alkylOC(O)NR 12 wherein R 12 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl and NR 13 R 14 C(O)—, wherein R 13 R 14 are each independently selected from the group of hydrogen, and an optionally substituted C 1 -C 8 alkyl.

22. The composition of claim 21 , wherein said compound has the formula

wherein:

R 2 is selected from an optionally substituted alkylcarbamoyl group, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and an optionally substituted ureido.

23. The composition of claim 21 , wherein said compound has the formula

wherein:

R 2 is selected from an optionally substituted C 1 -C 6 alkylcarbamoyl group, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and an optionally substituted ureido.

24. The composition of claim 16 , wherein said compound has the formula

wherein:

R 3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group.

25. The composition of claim 16 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkyl, an optionally substituted C 1 -C 8 alkoxy, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted carboxy, an optionally substituted carboxyalkyl, an optionally substituted carboxyalkenyl, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted carbamoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylalkyl, an optionally substituted C 1 -C 8 alkylthio, an optionally substituted C 1 -C 8 alkylsulfinyl, an optionally substituted C 1 -C 8 alkylsulfonyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aryl, an optionally substituted arylsulfinyl, an optionally substituted arylsulfonyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonyl, an optionally substituted amino, and an acid isostere;

R 3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group; or

R 2 and R 3 , together with the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring.

26. The composition of claim 16 , wherein said compound has the formula

wherein:

R 2 is selected from an optionally substituted C 1 -C 6 alkylcarbamoyl group, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and an optionally substituted ureido.

27. The composition of claim 15 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkoxy, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted carbamoyl, an optionally substituted amino, and an optionally substituted carboxy;

n is a value of about 1 to 2;

R 2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted amino, an optionally substituted carboxy, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy;

R 3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkoxycarbonyl, and an optionally substituted carboxy; and

R 6 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl; and

Q, Y and Z are each independently selected from the group consisting of a carbon, an optionally substituted nitrogen, an oxygen and a sulfur, provided however at least one of Q, Y and Z is carbon.

28. The composition of claim 27 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkoxy, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted carbamoyl, an optionally substituted amino, and an optionally substituted carboxy;

n is a value of about 1 to 2; and

R 2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted amino, and an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy.

29. A method for treating a condition in a mammal by decreasing or inhibiting the serine protease activity of matriptase or MTSP1, wherein the condition is selected from the group consisting of leukemia, lymphomas, breast cancer, gastrointestinal cancer, esophageal cancer, stomach cancer, colon cancer, bowel cancer, colorectal cancer, prostate cancer, bladder cancer, testicular cancer, ovarian cancer, uterine cancer, cervical cancer, brain cancer, lung cancer, bronchial cancer, pancreatic cancer, thyroid cancer, bone cancer and skin cancer, said method comprising: administering an effective amount of a compound of the formula:

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkyl, an optionally substituted C 1 -C 8 alkoxy, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted carboxy, an optionally substituted carboxyalkyl, an optionally substituted carboxyalkenyl, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted carbamoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylalkyl, an optionally substituted C 1 -C 8 alkylthio, an optionally substituted C 1 -C 8 alkylsulfinyl, an optionally substituted C 1 -C 8 alkylsulfonyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aryl, an optionally substituted arylsulfinyl, an optionally substituted arylsulfonyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonyl, an optionally substituted amino, and an acid isostere;

n is a value of 0 to about 6;

R 2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylalkyl, an optionally substituted amino, an optionally substituted carbamoyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroararyl, an optionally substituted cycloalkyl, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy; or

R 1 , R 2 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;

R 3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group; or

R 1 and R 3 , or R 2 and R 3 , together with the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;

R 4 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl; or

R 3 , R 4 , or R 2 , R 4 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;

R 5 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl, an optionally substituted aralkyl, or, alternatively, R 4 , R 5 and the atoms to which they are attached, join to form a 5- or 6-membered heterocyclic or heteroaryl ring;

R 6 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl; or

R 5 , R 6 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;

‘A’ is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkylene, a five- or a six-membered optionally substituted cycloalkyl group, a 5 to 10-membered optionally substituted aryl group and a 5 to 10-membered optionally substituted heteroaryl group, wherein said 5 to 10-membered optionally substituted heteroaryl group has from 1 to 3 heteroatoms selected from the group consisting of optionally substituted N, O, and S, wherein ‘A’ can optionally have a heteroatom for attachment;

X is a heteroatom selected from the group consisting of S, O and N;

R 7 , if present, is a member selected from the group consisting of hydrogen, hydroxy, an optionally substituted C 1 -C 8 alkyl, an optionally substituted C 1 -C 8 alkoxy, an optionally substituted aryl, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted C 1 -C 8 alkanoyloxy, an optionally substituted alkylcarbamoyl, an optionally substituted alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonyloxy; alternatively, A, R 7 , and the atoms to which they are attached, join to form a 5- to 10-membered optionally substituted heteroaryl group, wherein said 5- to 10-membered optionally substituted heteroaryl group has at least 1 optionally substituted nitrogen and the dotted line is either a bond or is absent; and

R 8 and R 9 are members independently selected from the group consisting of hydrogen, hydroxy, an optionally substituted C 1 -C 8 alkyl, an optionally substituted alkoxy, an optionally substituted aryl, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted alkanoyloxy, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted alkoxycarbonyl, and an optionally substituted C 1 -C 8 alkoxycarbonyloxy, in an alternative embodiment, R 7 and R 9 and the atoms to which they are attached, join to form a 5- to 7-membered heterocyclic or heteroaryl ring, to decrease or inhibit the serine protease activity of matriptase or MTSP1.

30. The method of claim 29 , wherein

is a member selected from the group consisting of:

wherein R 11 is a member selected from the group consisting of hydrogen, hydroxyl, and an optionally substituted C 1 -C 8 alkyl; and

Q, Y and Z are each independently selected from the group consisting of an optionally substituted carbon, an optionally substituted nitrogen, an oxygen and a sulfur, provided however at least one of Q, Y and Z is carbon and wherein the dotted line is an optional double bond.

31. The method of claim 30 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkoxy, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted amino, an optionally substituted carbamoyl, an optionally substituted C 1 -C 8 alkylsulfonyl, an optionally substituted aryl, optionally substituted arylsulfonyl, and a carboxylic acid isostere;

n is a value of about 1 to 4;

R 2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted amino, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy;

R 3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted aralkyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted heteroaralkyl, and an optionally substituted carboxy; and

R 5 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl.

32. The method of claim 31 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkoxy, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted amino, and an optionally substituted carboxy an optionally substituted carbamoyl, an optionally substituted C 1 -C 8 alkylsulfonyl, an optionally substituted aralkylsulfonyl, optionally substituted arylsulfonyl, and an acid isostere;

n is a value of about 1 to 2;

R 2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted amino, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted carbamoyl, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted heteroarylalkylsulfonamide, an optionally substituted arylsulfonylcarbamoyl and hydroxy; and

R 6 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl.

33. The method of claim 31 , wherein R 2 is selected from an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted ureido, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and hydroxy.

34. The method of claim 31 , wherein R 2 is an optionally substituted C 1 -C 8 alkoxycarbonyl.

35. The method of claim 30 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an C 1 -C 6 alkyl, carboxyl group, C 1 -C 6 alkyl-OC(O)NH—, C 1 -C 6 alkylOC(O)—, C 1 -C 6 alkylC(O)—, C 1 -C 6 alkylSO 2 —, C 1 -C 6 alkylOC(O)NR 12 wherein R 12 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl and NR 13 R 14 C(O)—, wherein R 13 R 14 are each independently selected from the group of hydrogen, and an optionally substituted C 1 -C 8 alkyl.

36. The method of claim 35 , wherein said compound has the formula

wherein:

R 2 is selected from an optionally substituted alkylcarbamoyl group, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and an optionally substituted ureido.

37. The method of claim 35 , wherein said compound has the formula

wherein:

R 2 is selected from an optionally substituted C 1 -C 6 alkylcarbamoyl group, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and an optionally substituted ureido.

38. The method of claim 30 , wherein said compound has the formula

wherein:

R 3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group.

39. The method of claim 30 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkyl, an optionally substituted C 1 -C 8 alkoxy, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted carboxy, an optionally substituted carboxyalkyl, an optionally substituted carboxyalkenyl, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted carbamoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylalkyl, an optionally substituted C 1 -C 8 alkylthio, an optionally substituted C 1 -C 8 alkylsulfinyl, an optionally substituted C 1 -C 8 alkylsulfonyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aryl, an optionally substituted arylsulfinyl, an optionally substituted arylsulfonyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonyl, an optionally substituted amino, and an acid isostere;

R 3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group; or

R 2 and R 3 , together with the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring.

40. The method of claim 30 , wherein said compound has the formula

wherein:

R 2 is selected from an optionally substituted C 1 -C 6 alkylcarbamoyl group, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted heteroarylalkylsulfonamide, and an optionally substituted ureido.

41. The method of claim 29 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkoxy, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted carbamoyl, an optionally substituted amino, and an optionally substituted carboxy;

n is a value of about 1 to 2;

R 2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted amino, an optionally substituted carboxy, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy;

R 3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkoxycarbonyl, and an optionally substituted carboxy; and

R 6 is a member selected from the group consisting of hydrogen, an optionally substituted C 1 -C 8 alkyl, and an optionally substituted aryl; and

Q, Y and Z are each independently selected from the group consisting of a carbon, an optionally substituted nitrogen, an oxygen and a sulfur, provided however at least one of Q, Y and Z is carbon.

42. The method of claim 41 , wherein said compound has the formula

wherein:

R 1 is a member selected from the group consisting of an optionally substituted C 1 -C 8 alkoxy, an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkanoyl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted carbamoyl, an optionally substituted amino, and an optionally substituted carboxy;

n is a value of about 1 to 2; and

R 2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C 1 -C 8 alkylcarbamoyl, an optionally substituted C 1 -C 8 alkoxycarbonyl, an optionally substituted amino, and an optionally substituted carboxy, an optionally substituted C 1 -C 8 alkoxycarbonylamino, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C 1 -C 8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy.

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 042389 FRAME: 505. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Feb 14, 2018
From: DENDREON PHARMACEUTICALS, INC.
To: DENDREON PHARMACEUTICALS LLC
Reel/Frame 046088/0882 →
RELEASE OF SECURITY INTEREST Recorded Jul 5, 2017
From: BARCLAYS BANK PLC
To: DENDREON PHARMACEUTICALS LLC
Reel/Frame 043089/0288 →
CHANGE OF NAME Recorded May 3, 2017
From: DENDREON PHARMACEUTICALS, INC.
To: DENDREON PHARMACEUTICALS LLC
Reel/Frame 042389/0505 →
SECURITY AGREEMENT Recorded Jul 27, 2015
From: DENDREON PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 036190/0503 →
CHANGE OF NAME Recorded Jul 20, 2015
From: DRONE ACQUISITION SUB INC.
To: DENDREON PHARMACEUTICALS, INC.
Reel/Frame 036136/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2015
From: DENDREON CORPORATION, AND ITS WHOLLY OWNED SUBSIDIARIES, DENDREON HOLDINGS, LLC, DENDREON DISTRIBUTION, LLC, AND DENDREON MANUFACTORING, LLC
To: DRONE ACQUISITION SUB INC.
Reel/Frame 036126/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2004
From: DUNCAN, DAVID F.; ALFARO-LOPEZ, L. JOSUE; KOMANDLA, MALLAREDDY; LEVY, ODILE ESTHER; MORENO, OFIR; SEMPLE, JOSEPH E.; TAMIZ, AMIR P.
To: DENDREON CORPORATION
Reel/Frame 014682/0960 →